Latest Breaking News On - சண்டீப் கபாடியா - Page 2 : comparemela.com
Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Passage Bio, Inc S-3ASR Mar 5, 2021 5:22 PM
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2020 Intercept Pharmaceuticals Earnings Call. [Operator Instructions]
I d now like to hand the conference over to your host today, Ms. Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs. Please go ahead.
Lisa DeFrancesco
Senior Vice President, Corporate Affairs & Investor Relations
Thank you. Good morning, and thank you for joining us on today s call. This morning we issued a press release announcing our fourth quarter and full year 2020 results and financial position, which is available on our website at www.interceptpharma.com.
Before we begin our discussion, I d like to note that during the call we will be making forward-looking statements, including statements regarding our approved products and clinical development program, certain regulatory matters and our strategy, prospects, financial guidance and future, commercial and financial performance. Li
Published: Dec 18, 2020 By Alex Keown
Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk.
VectivBio Appoints Sandip Kapadia to its Board of Directors
News provided by
Share this article
Share this article
BASEL, Switzerland, Dec. 15, 2020 /PRNewswire/ VectivBio Holding AG, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, today announced the appointment of Sandip Kapadia to its Board of Directors. We ve had a very productive partnership with Sandip previously and I am delighted to welcome Sandip to our Board, said Luca Santarelli, M.D., Chief Executive Officer of VectivBio. His deep pharmaceutical knowledge and financial expertise will be integral as VectivBio continues to grow and evolve.
Mr. Kapadia has over 20 years of life science industry experience. He currently serves as Chief Financial Officer of Intercept Pharmaceuticals. Mr. Kapadia held numerous finance leadership positions at Novartis and its affiliates in the United Kingdom, Netherlands, Switzerland and the United States, most re
vimarsana © 2020. All Rights Reserved.